Anti-IP10 抗体 (ab9938)
Key features and details
- Rabbit polyclonal to IP10
- Suitable for: WB
- Reacts with: Mouse
- Isotype: unknown
製品の概要
-
製品名
Anti-IP10 antibody
IP10 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to IP10 -
由来種
Rabbit -
特異性
This antibody does not cross-react with murine CXCL9 and CXCL11. -
アプリケーション
適用あり: WBmore details -
種交差性
交差種: Mouse -
免疫原
Recombinant full length protein corresponding to Mouse IP10. Highly pure (>98%) recombinant mIP-10 ( mouse Interferon Inducible Protein 10)
Database link: P17515 -
ポジティブ・コントロール
- Recombinant mouse IP10 protein (ab9944) can be used as a positive control in WB.
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Lyophilized:Reconstitute with 200µl of sterile water. -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
バッファー
No preservative, sterile filtered -
Concentration information loading...
-
精製度
Immunogen affinity purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
unknown -
軽鎖の種類
unknown -
研究分野
関連製品
-
Compatible Secondaries
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab9938の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (1) |
Use at an assay dependent concentration. To detect mIP-10 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant mIP-10 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
|
特記事項 |
---|
WB
Use at an assay dependent concentration. To detect mIP-10 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant mIP-10 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. |
ターゲット情報
-
機能
Chemotactic for monocytes and T-lymphocytes. Binds to CXCR3. -
配列類似性
Belongs to the intercrine alpha (chemokine CxC) family. -
翻訳後修飾
CXCL10(1-73) is produced by proteolytic cleavage after secretion from keratinocytes. -
細胞内局在
Secreted. - Information by UniProt
-
参照データベース
- Entrez Gene: 15945 Mouse
- SwissProt: P17515 Mouse
-
別名
- Interferon gamma induced factor MOB1, mouse, homolog of antibody
- Interferon gamma induced protein 10 antibody
- 10 kDa interferon gamma induced protein antibody
see all
画像
-
Western blot performed with ab9938 at 0.2 ug/ml
Lane 1: MultiMark MultiColor Standard (Invitrogen)
Lane 2: 250 ng Murine IP-10
Lane 3: 125 ng Murine IP-10
Lane 4: 62.5 ng Murine IP-10
Lane 5: 31.25 ng Murine IP-10
Lane 6: 15.625 ng Murine IP-10
Lane 7: 7.8 ng Murine IP-10
Lane 8: 3.9 ng Murine IP-10
Lane 9: 1.95 ng Murine IP-10
Lane 10: 0.975 ng Murine IP-10
Lane 11: 0.4875 ng Murine IP-10
Lane 12 0.24 ng Murine IP-10
プロトコール
データシートおよび資料
-
Datasheet download
参考文献 (11)
ab9938 は 11 報の論文で使用されています。
- Xiao M et al. Skin Wound following Irradiation Aggravates Radiation-Induced Brain Injury in a Mouse Model. Int J Mol Sci 24:N/A (2023). PubMed: 37445879
- Lien WC et al. Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation. Bioeng Transl Med 8:e10346 (2023). PubMed: 36684074
- Dorrier CE et al. CNS fibroblasts form a fibrotic scar in response to immune cell infiltration. Nat Neurosci 24:234-244 (2021). PubMed: 33526922
- Guo CH et al. Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice. Mar Drugs 19:N/A (2021). PubMed: 33805447
- Clé M et al. Study of Usutu virus neuropathogenicity in mice and human cellular models. PLoS Negl Trop Dis 14:e0008223 (2020). PubMed: 32324736